Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Zoetis Inc.. A complete text table follows the diagram.
Companion-animal medicine still supplies two-thirds of sales, but livestock products and international markets carried the quarter as the U.S. pet portfolio contracted.
Swipe to explore
Every Sankey link is a reported geography and animal-market revenue amount. The visual emphasizes the mix shift toward international livestock rather than presenting a conventional income statement.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| United States | 1 | $1.1B | 48% of company revenue |
| International markets | 1 | $1.1B | 51% of company revenue |
| Contract manufacturing and human health | 1 | $23M | Small non-animal-health stream |
| Companion animal medicine | 2 | $1.5B | Dogs, cats and horses |
| Livestock medicine | 2 | $720M | Cattle, swine, poultry and fish |
| Other health revenue | 2 | $23M | Contract and human-health work |
| Animal-health portfolio revenue | 3 | $2.3B | Global species and geography mix |
| From | To | Value |
|---|---|---|
| United States | Companion animal medicine | $865M |
| United States | Livestock medicine | $225M |
| International markets | Companion animal medicine | $654M |
| International markets | Livestock medicine | $495M |
| Contract manufacturing and human health | Other health revenue | $23M |
| Companion animal medicine | Animal-health portfolio revenue | $1.5B |
| Livestock medicine | Animal-health portfolio revenue | $720M |
| Other health revenue | Animal-health portfolio revenue | $23M |